Clinical trial
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
NCT07651852 is registered in ClinicalTrials.gov with Kardium Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
- Lead sponsor
- Kardium Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- October 31, 2029
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.